Talk to Us

Aetna prior authorization J9999

Aetna prior authorization for J9999: Amtagvi (lifileucel,) — precertification required for the drug and site of care Contact National Medical Excellence

Code
J9999
Description
Amtagvi (lifileucel,) — precertification required for the drug and site of care Contact National Medical Excellence
Description
Avzivi (bevacizumab-tnjn,)— precertification required for the drug and site of care effective October 1, 2026
Description
)— precertification required for drug and
Description
Immunnologics agents (continued): Zimrixby (rituximab-cdxx,) — precertification required for drug and
Description
Ophthalmic injectables: Lytenava (bevacizumab-vikg,) — precertification required effective
Description
Revtorpyk (gedatolisib,)— precertification required effective September 1, 2026
Description
Sarclisa Escena SC (isatuximab-irfc) — precertification required effective September 1, 2026
Source
Participating provider precertification list for Aetna, Pg 20 Original policy
Source
Participating provider precertification list for Aetna, Pg 20 Original policy
Source
Participating provider precertification list for Aetna, Pg 25 Original policy
Source
Participating provider precertification list for Aetna, Pg 26 Original policy
Source
Participating provider precertification list for Aetna, Pg 29 Original policy
Source
Participating provider precertification list for Aetna, Pg 32 Original policy
Source
Participating provider precertification list for Aetna, Pg 32 Original policy

Aetna prior authorization

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.

This website uses cookies to ensure you get the best experience on our website. Learn more